Floatz logo

BLEOMYCIN

Lymphoma

Shandong Provincial HospitalmixturePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
75/ 100
Competitive Position
65/ 100

Competitive context

288 Active assets in the Lymphoma cohort.

Asset / SponsorPhaseRating
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
The Lymphoma Academic Research Organisation
Phase 4BBB
VINBLASTINE
Intensity Therapeutics, Inc.
Phase 4BBB
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
(+)-VINCRISTINE
Beth Israel Deaconess Medical Center
Phase 4BB
FILGRASTIM
M.D. Anderson Cancer Center
Phase 4BB

View all 50 →

Same molecule, other indications

BLEOMYCIN is also rated in:

Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BB
Indicative ·
71 / 100
View asset →
extragonadal germ cell tumorDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →